|
|||
2009-09-24 11:28:00 CEST 2009-09-24 11:28:19 CEST REGULATED INFORMATION Biohit Oyj - Changes board/management/auditorsDIRECTOR OF BIOHIT'S DIAGNOSTICS BUSINESS RESIGNSBIOHIT OYJ STOCK EXCHANGE RELEASE ON 24 SEPTEMBER 2009 AT 12:25 DIRECTOR OF BIOHIT'S DIAGNOSTICS BUSINESS RESIGNS Peter Tchernych, Director of Biohit Oyj's diagnostics business, has today given notice of his resignation from the company's employment due to personal reasons. He will leave the company with immediate effect. For the time being, President & CEO Osmo Suovaniemi will take care of the international sales and management of the diagnostics business together with Sales Director Päivi Lipponen (MSc) and R&D Director Lea Paloheimo (PhD). Päivi Lipponen has been with Biohit since 2008 and Lea Paloheimo since 2001. Biohit Oyj Osmo Suovaniemi President & CEO Further information: Osmo Suovaniemi, M.D., Ph.D., Professor President & CEO Tel: +358-9-773 861 GSM: +358-40-745 5605 Email: osmo.suovaniemi@biohit.com Distribution: NASDAQ OMX Helsinki Oy Central storage facility (www.oam.fi) Press www.biohit.com About Biohit Oyj Biohit Oyj develops, manufactures and markets liquid handling products and diagnostic test systems for use in research, health care and industrial laboratories. Liquid handling products include electronic and mechanical pipettes and dispensers, and disposable tips, as well as pipette maintenance and calibration services. Diagnostics business comprises products and analysis systems for diagnosing, screening and prevention of gastrointestinal diseases, e.g. the blood-sample based GastroPanel and GastroView, for diagnosing diseases of the stomach and associated risks, as well as quick tests for the diagnosis of lactose intolerance, H. pylori infection and fecal occult blood. Biohit Oyj is headquartered in Finland. Biohit has subsidiaries in France, Germany, the UK, Russia, China, Japan and the USA. Additionally, Biohit's products are sold by approximately 450 distributors in 70 countries. Biohit's share (BIOBV) is quoted on NASDAQ OMX Helsinki. Read more at www.biohit.com |
|||
|